Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Bollard

Showing results (1-10 of 290) with videos related to

Pageof 29
Sort By:
Pediatric Hematology and Oncology|July 24, 2014
A change in the editorial office: farewell from Catherine M. BollardCatherine M Bollard
Cytotherapy|October 15, 2010
Isolating cytomegalovirus-specific T cells for adoptive transfer: are we there yet?Catherine M Bollard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Improving T-cell therapy for epstein-barr virus lymphoproliferative disordersCatherine M Bollard
Blood|July 7, 2021
Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophiliaCatherine M Bollard
Blood|March 11, 2022
Introduction to a review series on immunotherapies for nonmalignant hematologic diseasesCatherine M Bollard
Frontiers in Immunology|October 28, 2017
Virus-Specific T Cells for the Immunocompromised PatientAmy Houghtelin, Catherine M Bollard
Blood Advances|January 4, 2018
Developing T-cell therapies for lymphoma without receptor engineeringMelanie Grant, Catherine M Bollard
Blood Advances|December 26, 2023
Celebrating a year of cancer research in Blood AdvancesCatherine M Bollard, Andrew Weyrich
Blood|August 26, 2021
EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic targetKeri Toner, Catherine M Bollard
Immunotherapy|April 20, 2012
T-cell therapy for cancerJohn Barrett, Catherine M Bollard
Pageof 29

Showing results (1-10 of 290) with videos related to

Sort By:
Pageof 29
Pediatric Hematology and Oncology|July 24, 2014
A change in the editorial office: farewell from Catherine M. BollardCatherine M Bollard
Cytotherapy|October 15, 2010
Isolating cytomegalovirus-specific T cells for adoptive transfer: are we there yet?Catherine M Bollard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Improving T-cell therapy for epstein-barr virus lymphoproliferative disordersCatherine M Bollard
Blood|July 7, 2021
Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophiliaCatherine M Bollard
Blood|March 11, 2022
Introduction to a review series on immunotherapies for nonmalignant hematologic diseasesCatherine M Bollard
Frontiers in Immunology|October 28, 2017
Virus-Specific T Cells for the Immunocompromised PatientAmy Houghtelin, Catherine M Bollard
Blood Advances|January 4, 2018
Developing T-cell therapies for lymphoma without receptor engineeringMelanie Grant, Catherine M Bollard
Blood Advances|December 26, 2023
Celebrating a year of cancer research in Blood AdvancesCatherine M Bollard, Andrew Weyrich
Blood|August 26, 2021
EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic targetKeri Toner, Catherine M Bollard
Immunotherapy|April 20, 2012
T-cell therapy for cancerJohn Barrett, Catherine M Bollard
Pageof 29